☆ 4.7 Article

Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network

JOURNAL OF AUTOIMMUNITY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Rheumatology

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

Florence Aeschlimann et al.

Summary: In this French cohort study of RMD COVID-19 patients, older age, male gender, obesity, and hypertension were found to be associated with severe COVID-19, similar to the general population. Patients with iRMD on corticosteroids, but not methotrexate, tumor necrosis factor alpha, and interleukin-6 inhibitors, were more likely to develop severe COVID-19. Unlike common comorbidities, such as obesity, cardiovascular or lung diseases, the risk of death in patients with iRMD was not significantly increased.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Review Immunology

Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data

Chuanhui Xu et al.

Summary: Patients with rheumatic diseases infected with COVID-19 have a higher rate of severe outcomes, especially in Europe. More studies are needed to understand the risk factors for severe outcomes in this population.

AUTOIMMUNITY REVIEWS (2021)

添加到收藏夹

Article Immunology

Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies-A Danish population-based cohort study

Mohamed Attauabi et al.

Summary: The study found a lower occurrence but a more severe disease course of COVID-19 among patients with IMIDs, associated with the use of systemic steroids and suspension of other immunosuppressants. Therefore, it emphasizes the importance of weighing risks before suspending immunosuppressants during COVID-19.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

Article Rheumatology

Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States

Rahul Raiker et al.

Summary: The study found that before matching, RA patients had higher risks compared to non-RA patients in COVID-19 outcomes, but after matching, most outcomes showed no significant difference, implying the risk may be attributed to adjusted factors. However, after matching, the risks of VTE and sepsis were still higher in the RA cohort, indicating RA as an independent risk factor.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

添加到收藏夹

Review Rheumatology

Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis

Qingxiu Wang et al.

Summary: Rheumatic patients are at a significantly higher risk of COVID-19 infection compared to the general population, but show similar hospitalization and severe clinical outcomes. Comorbidities, hypertension, lung diseases, and older age are associated with increased risk of COVID-19-related hospitalization in rheumatic patients, while the use of anti-TNF drugs is linked to lower hospitalization risk.

RHEUMATOLOGY INTERNATIONAL (2021)

添加到收藏夹

Article Clinical Neurology

Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Michala Jakubikova et al.

Summary: In MG patients, lower FVC, long-term high-dose corticosteroid treatment, older age, presence of cancer, and recent rituximab treatment were identified as the most important predictors of severe COVID-19.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Review Immunology

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets

Jon Hazeldine et al.

Summary: Approximately 20% of individuals infected with SARS-CoV-2 may progress to severe respiratory complications, with a hyperactive and dysregulated immune response potentially underpinning the development of severe disease, particularly through the involvement of neutrophils. Evaluating the number, maturity status and function of circulating neutrophils at hospital admission shows promise as a prognostic tool for early identification of patients at risk of clinical deterioration. Targeting neutrophils as a potential therapeutic strategy for severe COVID-19 warrants further investigation, given the limited specific treatments currently available.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Rheumatology

Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR)

Chengappa Kavadichanda et al.

Summary: The study found that individuals with scleroderma in India were significantly impacted during the COVID-19 pandemic due to the closure of hospital services, lack of transportation, job loss, and additional financial burden. Healthcare providers should continue educating patients to adhere to medication and encourage them to get vaccinated for COVID-19.

RHEUMATOLOGY ADVANCES IN PRACTICE (2021)

添加到收藏夹

Article Rheumatology

Treatment Adherence and Disease Status among Children with Rheumatological Diseases during COVID-19 Pandemic: A Cross-Sectional Study from a Tertiary Care Center

Sabarinath Mahadevan et al.

Summary: During the COVID-19 pandemic, children with rheumatological diseases faced challenges in treatment adherence, with common flare symptoms being joint pain, skin rashes, and oral ulcers. Parental awareness of electronic consultation portals was found to be low.

INDIAN JOURNAL OF RHEUMATOLOGY (2021)

添加到收藏夹

Review Rheumatology

Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review

Muhanad Taha et al.

Summary: aPLs were detected in nearly half of patients with COVID-19, and higher prevalence of aPL was found in severe disease. However, there was no association between aPL positivity and disease outcomes including thrombosis, invasive ventilation and mortality. Further studies are required to identify the clinical and pathological role of aPL in COVID-19.

RMD OPEN (2021)

添加到收藏夹

Article Health Care Sciences & Services

Health outcomes and economic burden of hospitalized COVID-19 patients in the United States

Manuela Di Fusco et al.

Summary: This study evaluated health outcomes and economic burden of hospitalized COVID-19 patients in the US. Among 173,942 patients, the median age was 63 years, with 51% male and 48.5% covered by Medicare. The most prevalent medical conditions were cardiovascular disease, hypertension, diabetes, obesity, and chronic kidney disease. Around one-fifth were admitted to the ICU, 16.9% received IMV, and most did not require these interventions.

JOURNAL OF MEDICAL ECONOMICS (2021)

添加到收藏夹

Article Rheumatology

COVID-19 and myositis - unique challenges for patients

Latika Gupta et al.

Summary: The COVID-19 pandemic has had a significant impact on the management of patients with idiopathic inflammatory myopathies (IIM), leading to difficulties in disease control, continuity of medical care, and procuring medications. Many patients faced challenges in accessing healthcare during the pandemic, raising concerns about potential worsening outcomes.

RHEUMATOLOGY (2021)

添加到收藏夹

Letter Rheumatology

The Plight of Patients with Lupus Nephritis during the Outbreak of COVID-19 in Wuhan, China

Cheng Chen et al.

JOURNAL OF RHEUMATOLOGY (2020)

添加到收藏夹

Article Rheumatology

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Jose L. Pablos et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Review Rheumatology

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad

Sakir Ahmed et al.

CLINICAL RHEUMATOLOGY (2020)

添加到收藏夹

Article Rheumatology

Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus

Ruth Fernandez-Ruiz et al.

ARTHRITIS & RHEUMATOLOGY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020

Erin K. Stokes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of Obesity on Outcomes of Patients With Coronavirus Disease 2019 in the United States: A Multicenter Electronic Health Records Network Study

Shailendra Singh et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Review Integrative & Complementary Medicine

Predictors of mortality in patients with COVID-19-a systematic review

Esmaeil Mehraeen et al.

EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Stephanie L. Harrison et al.

PLOS MEDICINE (2020)

添加到收藏夹

Article Cell Biology

Evolution of COVID-19 in patients with autoimmune rheumatic diseases

Rongrong Pang et al.

AGING-US (2020)

添加到收藏夹

Letter Rheumatology

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Alexis Mathian et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Interferon Alpha as a Primary Pathogenic Factor in Human Lupus

Timothy B. Niewold

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)

添加到收藏夹

Article Pharmacology & Pharmacy

Economic Outcomes in Patients Diagnosed With Systemic Lupus Erythematosus With Versus Without Nephritis: Results From an Analysis of Data From a US Claims Database

Elise M. Pelletier et al.

CLINICAL THERAPEUTICS (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.